Amsterdam, the Netherlands, November 10, 2014 - uniQure N.V. (Nasdaq: QURE), a leader in human gene therapy, today announced that Jörn Aldag, CEO, will present a corporate overview at Jefferies Global Healthcare Conference - London, to be held November 19-20, 2014.
Mr. Aldag’s presentation will take place November 19, 10:40-11:20 a.m. (GMT).
To access a simultaneous webcast of Mr. Aldag’s presentation via the internet, log on to the “Events” section on the Media page of the uniQure website at http://www.uniqure.com/news/calendar-of-events/.
A replay of the webcast will be available from uniQure’s website for 30 days following the conference. Mr. Aldag’s presentation will be available for download in PDF format immediately following the conference presentation in the “Events” section of the Media page of uniQure’s website at http://www.uniqure.com/news/calendar-of-events/.
About uniQure
uniQure is delivering on the promise of gene therapy through single treatments with potentially curative results. We have developed a modular platform to rapidly bring new disease-modifying therapies to patients with severe disorders. We are engaged in multiple partnerships and have obtained regulatory approval of our lead product, Glybera, in the European Union for a subset of patients with LPLD. www.uniQure.com
uniQure:
Aicha Diba
Investor Relations
Direct: +31 20 240 6100
Main: +31 20 566 7394
a.diba@uniQure.com
Media inquiries:
Gretchen Schweitzer
MacDougall Biomedical Communications
Direct: +49 172 861 8540
Main: +1 781 235 3060
gschweitzer@macbiocom.com
Help employers find you! Check out all the jobs and post your resume.
